×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IRMD – iradimed corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IRMD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/25
08:33 pm
irmd
IRADIMED CORPORATION's (NASDAQ:IRMD) Stock Is Going Strong: Is the Market Following Fundamentals? [Yahoo! Finance]
Low
Report
IRADIMED CORPORATION's (NASDAQ:IRMD) Stock Is Going Strong: Is the Market Following Fundamentals? [Yahoo! Finance]
1/19
09:10 am
irmd
IRadimed Corporation (IRMD): Accelerating with Solid Capital Return [Yahoo! Finance]
Low
Report
IRadimed Corporation (IRMD): Accelerating with Solid Capital Return [Yahoo! Finance]
12/25
05:57 am
irmd
IRADIMED's (NASDAQ:IRMD) investors will be pleased with their incredible 352% return over the last five years [Yahoo! Finance]
Low
Report
IRADIMED's (NASDAQ:IRMD) investors will be pleased with their incredible 352% return over the last five years [Yahoo! Finance]
12/17
04:35 pm
irmd
iRadimed (NASDAQ:IRMD) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
iRadimed (NASDAQ:IRMD) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.
12/16
11:10 am
irmd
What Makes IRADIMED CORPORATION (IRMD) a Compelling Opportunity? [Yahoo! Finance]
Low
Report
What Makes IRADIMED CORPORATION (IRMD) a Compelling Opportunity? [Yahoo! Finance]
12/11
04:19 pm
irmd
iRadimed (NASDAQ:IRMD) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
iRadimed (NASDAQ:IRMD) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.
12/8
08:30 am
irmd
IRADIMED Announces Special Cash Dividend of $0.50 Per Share
Low
Report
IRADIMED Announces Special Cash Dividend of $0.50 Per Share
12/5
04:23 pm
irmd
iRadimed (NASDAQ:IRMD) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
iRadimed (NASDAQ:IRMD) had its "buy (b-)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
1/27
05:00 pm
irmd
Form 4 IRADIMED CORP For: Jan 26 Filed by: Susi Roger E.
Low
Report
Form 4 IRADIMED CORP For: Jan 26 Filed by: Susi Roger E.
1/21
04:05 pm
irmd
Form 4 IRADIMED CORP For: Jan 20 Filed by: Susi Roger E.
Low
Report
Form 4 IRADIMED CORP For: Jan 20 Filed by: Susi Roger E.
1/13
04:20 pm
irmd
Form 4 IRADIMED CORP For: Jan 12 Filed by: Susi Roger E.
Low
Report
Form 4 IRADIMED CORP For: Jan 12 Filed by: Susi Roger E.
1/6
04:05 pm
irmd
Form 4 IRADIMED CORP For: Jan 05 Filed by: Susi Roger E.
Low
Report
Form 4 IRADIMED CORP For: Jan 05 Filed by: Susi Roger E.
12/30
04:06 pm
irmd
Form 4 IRADIMED CORP For: Dec 29 Filed by: Susi Roger E.
Low
Report
Form 4 IRADIMED CORP For: Dec 29 Filed by: Susi Roger E.
12/22
04:10 pm
irmd
Form 4 IRADIMED CORP For: Dec 22 Filed by: Susi Roger E.
Low
Report
Form 4 IRADIMED CORP For: Dec 22 Filed by: Susi Roger E.
12/17
04:05 pm
irmd
Form 4 IRADIMED CORP For: Dec 15 Filed by: Susi Roger E.
Low
Report
Form 4 IRADIMED CORP For: Dec 15 Filed by: Susi Roger E.
12/15
05:30 pm
irmd
Form 4 IRADIMED CORP For: Dec 11 Filed by: ALLEN MONTY K
Low
Report
Form 4 IRADIMED CORP For: Dec 11 Filed by: ALLEN MONTY K
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
7/29
Form 8-K IRADIMED CORP For: Jul 29
33.3%
9/12 Form 4 IRADIMED CORP For: Sep 10 Filed by: JOHNSON BRENT 13.4%
3/24 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $18.00 price target on the stock. 12.5%
3/31 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $21.00 price target on the stock. 9.7%
12/11 Form 4 IRADIMED CORP For: Dec 09 Filed by: JOHNSON BRENT 7.7%
2/6 IRADIMED CORPORATION Announces Fourth Quarter 2019 Financial Results 7.1%
4/3 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 6.9%
10/30 Q3/2019 9/30/2019 EPS 0.230 ZacksConsensus 0.130 ActVsEst 0.100 - Beat 5.7%
4/14 Iradimed Corp (NASDAQ: IRMD) had its price target lowered by analysts at Roth Capital from $32.00 to $30.00. 5.0%
8/7 Form 4 IRADIMED CORP For: Aug 05 Filed by: JOHNSON BRENT 4.9%
9/12 Form 4 IRADIMED CORP For: Sep 10 Filed by: JOHNSON BRENT 13.4%
3/24 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $18.00 price target on the stock. 12.5%
3/31 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $21.00 price target on the stock. 9.7%
12/11 Form 4 IRADIMED CORP For: Dec 09 Filed by: JOHNSON BRENT 7.7%
2/6 IRADIMED CORPORATION Announces Fourth Quarter 2019 Financial Results 7.1%
4/3 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 6.9%
10/30 Q3/2019 9/30/2019 EPS 0.230 ZacksConsensus 0.130 ActVsEst 0.100 - Beat 5.7%
4/14 Iradimed Corp (NASDAQ: IRMD) had its price target lowered by analysts at Roth Capital from $32.00 to $30.00. 5.0%
8/7 Form 4 IRADIMED CORP For: Aug 05 Filed by: JOHNSON BRENT 4.9%
TOP News Decliners
4/30
Form 8-K IRADIMED CORP For: Apr 30
-9.0%
3/12 IRADIMED CORPORATION Announces the Appointment of Lynn Neuhardt as Vice President of Research and Development -7.8%
5/7 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $28.00 price target on the stock. -6.1%
11/1 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.8%
2/25 Form 4 IRADIMED CORP For: Feb 24 Filed by: JOHNSON BRENT -5.6%
2/28 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -5.1%
8/5 Form 4 IRADIMED CORP For: Aug 01 Filed by: Waldman Louis S. -5.1%
11/5 Form 4 IRADIMED CORP For: Nov 04 Filed by: Nardi Steven M. -4.9%
3/26 Form 4 IRADIMED CORP For: Mar 24 Filed by: JOHNSON BRENT -4.5%
3/4 Form 4 IRADIMED CORP For: Mar 02 Filed by: JOHNSON BRENT -3.9%
3/12 IRADIMED CORPORATION Announces the Appointment of Lynn Neuhardt as Vice President of Research and Development -7.8%
5/7 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $28.00 price target on the stock. -6.1%
11/1 Iradimed Corp (NASDAQ: IRMD) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.8%
2/25 Form 4 IRADIMED CORP For: Feb 24 Filed by: JOHNSON BRENT -5.6%
2/28 Iradimed Corp (NASDAQ: IRMD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -5.1%
8/5 Form 4 IRADIMED CORP For: Aug 01 Filed by: Waldman Louis S. -5.1%
11/5 Form 4 IRADIMED CORP For: Nov 04 Filed by: Nardi Steven M. -4.9%
3/26 Form 4 IRADIMED CORP For: Mar 24 Filed by: JOHNSON BRENT -4.5%
3/4 Form 4 IRADIMED CORP For: Mar 02 Filed by: JOHNSON BRENT -3.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: